纤维肌痛

Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004;292:2388-2395.

• 全文
• 摘要

Rooks DS. Fibromyalgia treatment update. Curr Opin Rheumatol. 2007;19:111-117.

• 摘要

1.  Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160-172.

• 摘要

2.  Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62:600-610.

• 全文
• 摘要

3.  Topbas M, Cakirbay H, Gulec H, et al. The prevalence of fibromyalgia in women aged 20-64 in Turkey. Scand J Rheumatol. 2005;34:140-144.

• 摘要

4.  Haq SA, Darmawan J, Islam MN, et al. Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. J Rheumatol. 2005;32:348-353.

• 摘要

5.  White KP, Harth M. Classification, epidemiology, and natural history of fibromyalgia. Curr Pain Headache Rep. 2001;5:320-329.

• 摘要

6.  Wolfe F. The epidemiology of fibromyalgia. J Musculoskel Pain. 1993;1:137.

7.  Raspe H, Baumgartner C, Wolfe F. The prevalence of fibromyalgia in a rural German community: how much difference do criteria make? Arthritis Rheum. 1993;36(9 Suppl):S48.

8.  Vincent A, Lahr BD, Wolfe F, et al. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res (Hoboken). 2013;65:786-792.

• 摘要

9.  Wolfe F, Clauw DJ, Fitzcharles MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011;38:1113-1122.

• 摘要

10.  Arnold LM, Hudson JI, Hess EV, et al. Family study of fibromyalgia. Arthritis Rheum. 2004;50:944-952.

• 全文
• 摘要

11.  Hudson JI, Hudson MS, Pliner LF, et al. Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry. 1985;142:441-446.

• 摘要

12.  Mogil JS, Yu L, Basbaum AI. Pain genes?: natural variation and transgenic mutants. Annu Rev Neurosci. 2000;23:777-811.

• 摘要

13.  Diatchenko L, Nackley AG, Tchivileva IE, et al. Genetic architecture of human pain perception. Trends Genet. 2007;23:605-613.

• 摘要

14.  Tegeder I, Costigan M, Griffin RS, et al. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med. 2006;12:1269-1277.

• 摘要

15.  Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet. 1999;354:936-939.

• 摘要

16.  Barsky AJ, Borus JF. Functional somatic syndromes. Ann Intern Med. 1999;130:910-921.

• 摘要

17.  Fukuda K, Nisenbaum R, Stewart G, et al. Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA. 1998;280:981-988.

• 全文
• 摘要

18.  Kato K, Sullivan PF, Evengard B, et al. Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med. 2006;166:1649-1654.

• 摘要

19.  Kato K, Sullivan PF, Evengard B, et al. A population-based twin study of functional somatic syndromes. Psychol Med. 2009;39:497-505.

• 摘要

20.  Markkula R, Järvinen P, Leino-Arjas P, et al. Clustering of symptoms associated with fibromyalgia in a Finnish twin cohort. Eur J Pain. 2009;13:744-750.

• 摘要

21.  Balagué F, Nordin M. Back pain in children and teenagers. Baillieres Clin Rheumatol. 1992;6:575-593.

• 摘要

22.  Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38:1569-1580.

• 摘要

23.  Aaron LA, Bradley LA, Alarcón GS, et al. Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum. 1996;39:436-445.

• 摘要

24.  Maixner W, Fillingim R, Booker D, et al. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain. Pain. 1995;63:341-351.

• 摘要

25.  Naliboff BD, Derbyshire SW, Munakata J, et al. Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med. 2001;63:365-375.

• 摘要

26.  Giesecke T, Gracely RH, Grant MA, et al. Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum. 2004;50:613-623.

• 全文
• 摘要

27.  Giesecke J, Reed BD, Haefner HK, et al. Quantitative sensory testing in vulvodynia patients and increased peripheral pressure pain sensitivity. Obstet Gynecol. 2004;104:126-133.

• 摘要

28.  Moshiree B, Price DD, Robinson ME, et al. Thermal and visceral hypersensitivity in irritable bowel syndrome patients with and without fibromyalgia. Clin J Pain. 2007;23:323-330.

• 摘要

29.  Greenspan JD, Slade GD, Bair E, et al. Pain sensitivity risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case control study. J Pain. 2011;12(11 Suppl):T61-T74.

• 全文
• 摘要

30.  Caro XJ, Winter EF, Dumas AJ. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg. Rheumatology (Oxford). 2008;47:208-211.

• 全文
• 摘要

31.  Kim SH, Kim DH, Oh DH, et al. Characteristic electron microscopic findings in the skin of patients with fibromyalgia - preliminary study. Clin Rheumatol. 2008;27:407-411.

• 摘要

32.  Oaklander AL, Fields HL. Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small-fiber neuropathy? Ann Neurol. 2009;65:629-638.

• 摘要

33.  Apkarian AV, Sosa Y, Sonty S, et al. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci. 2004;24:10410-10415.

• 全文
• 摘要

34.  Sundgren PC, Petrou M, Harris RE, et al. Diffusion-weighted and diffusion tensor imaging in fibromyalgia patients: a prospective study of whole brain diffusivity, apparent diffusion coefficient, and fraction anisotropy in different regions of the brain and correlation with symptom severity. Acad Radiol. 2007;14:839-846.

• 摘要

35.  Kuchinad A, Schweinhardt P, Seminowicz DA, et al. Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain? J Neurosci. 2007;27:4004-4007.

• 全文
• 摘要

36.  Luerding R, Weigand T, Bogdahn U, et al. Working memory performance is correlated with local brain morphology in the medial frontal and anterior cingulate cortex in fibromyalgia patients: structural correlates of pain-cognition interaction. Brain. 2008;131:3222-3231.

• 全文
• 摘要

37.  Lutz J, Jäger L, de Quervain D, et al. White and gray matter abnormalities in the brain of patients with fibromyalgia: a diffusion-tensor and volumetric imaging study. Arthritis Rheum. 2008;58:3960-3969.

• 全文
• 摘要

38.  Schmidt-Wilcke T. Variations in brain volume and regional morphology associated with chronic pain. Curr Rheumatol Rep. 2008;10:467-474.

• 摘要

39.  Hsu MC, Harris RE, Sundgren PC, et al. No consistent difference in gray matter volume between individuals with fibromyalgia and age-matched healthy subjects when controlling for affective disorder. Pain. 2009;143:262-267.

• 摘要

40.  Buskila D, Sarzi-Puttini P, Ablin JN. THe genetics of fibromyalgia syndrome. Pharmacogenomics. 2007;8:67-74.

• 摘要

41.  Buskila D, Sarzi-Puttini P. Biology and therapy of fibromyalgia: genetic aspects of fibromyalgia syndrome. Arthritis Res Ther. 2006;8:218.

• 全文
• 摘要

42.  Phillips K, Clauw DJ. Central pain mechanisms in chronic pain states - maybe it is all in their head. Best Pract Res Clin Rheumatol. 2011;25:141-154.

• 摘要

43.  Dadabhoy D, Crofford LJ, Spaeth M, et al. Biology and therapy of fibromyalgia: evidence-based biomarkers for fibromyalgia syndrome. Arthritis Res Ther. 2008;10:211.

• 全文
• 摘要

44.  Giesecke T, Williams DA, Harris RE, et al. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum. 2003;48;2916-2922.

• 全文
• 摘要

45.  Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004;292:2388-2395.

• 全文
• 摘要

46.  Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311:1547-1555.

• 摘要

47.  Bidonde J, Busch AJ, Schachter CL, et al. Aerobic exercise training for adults with fibromyalgia. Cochrane Database Syst Rev. 2017;(6):CD012700.

• 全文
• 摘要

48.  Wang C, Schmid CH, Rones R, et al. A randomized trial of tai chi for fibromyalgia. N Engl J Med. 2010;363:743-754.

• 全文
• 摘要

49.  Schmidt-Wilcke T, Clauw DJ. Fibromyalgia: from pathophysiology to therapy. Nat Rev Rheumatol. 2011;7:518-527.

• 摘要

50.  Clauw DJ. Pain management: Fibromyalgia drugs are 'as good as it gets' in chronic pain. Nat Rev Rheumatol. 2010;6:439-440.

• 摘要

51.  Mease PJ, Russell IJ, Kajdasz DK, et al. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia. Semin Arthritis Rheum. 2010;39:454-464.

• 摘要

52.  Brunton S, Wang F, Edwards SB, et al. Profile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studies. Drug Saf. 2010;33:393-407.

• 摘要

53.  Choy EH, Mease PJ, Kajdasz DK, et al. Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials. Clin Rheumatol. 2009;28:1035-1044.

• 全文
• 摘要

54.  Gendreau RM, Thorn MD, Gendreau JF, et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol. 2005;32:1975-1985.

• 摘要

55.  Mease PJ, Clauw DJ, Gendreau RM, et al. The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial. J Rheumatol. 2009;36:398-409.

• 摘要

56.  Clauw DJ, Mease P, Palmer RH, et al. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther. 2008;30:1988-2004.

• 摘要

57.  Kyle JA, Dugan BD, Testerman KK. Milnacipran for treatment of fibromyalgia. Ann Pharmacother. 2010;44:1422-1429.

• 摘要

58.  Arnold LM, Gendreau RM, Palmer RH, et al. Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2010;62:2745-2756.

• 摘要

59.  Branco JC, Zachrisson O, Perrot S, et al. A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia. J Rheumatol. 2010;37:851-859.

• 摘要

60.  Arnold LM, Keck PE Jr, Welge JA. Antidepressant treatment of fibromyalgia: a meta-analysis and review. Psychosomatics. 2000;41:104-113.

• 摘要

61.  Tofferi JK, Jackson JL, O'Malley PG. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum. 2004;51:9-13.

• 全文
• 摘要

62.  O'Malley PG, Balden E, Tomkins G, et al. Treatment of fibromyalgia with antidepressants. J Gen Intern Med. 2000;15:659-666.

• 全文
• 摘要

63.  Nishishinya B, Urrútia G, Walitt B, et al. Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy. Rheumatology (Oxford). 2008;47:1741-1746.

• 全文
• 摘要

64.  Häuser W, Bernardy K, Uçeyler N, et al. Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA. 2009;301:198-209.

• 全文
• 摘要

65.  Arnold LM, Chatamra K, Hirsch I, et al. Safety and efficacy of esreboxetine in patients with fibromyalgia: An 8-week, multicenter, randomized, double-blind, placebo-controlled study. Clin Ther. 2010;32:1618-1632.

• 摘要

66.  Arnold LM, Goldenberg DL, Stanford SB, et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum. 2007;56:1336-1344.

• 全文
• 摘要

67.  Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52:1264-1273.

• 全文
• 摘要

68.  Moore RA, Straube S, Wiffen PJ, et al. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009;(3):CD007076.

• 全文
• 摘要

69.  Häuser W, Bernardy K, Uçeyler N, et al. Treatment of fibromyalgia syndrome with gabapentin and pregabalin: a meta-analysis of randomized controlled trials. Pain. 2009;145:69-81.

• 摘要

70.  Busch AJ, Webber SC, Richards RS, et al. Resistance exercise training for fibromyalgia. Cochrane Database Syst Rev. 2013;(12):CD010884.

• 全文
• 摘要

71.  Bernardy K, Klose P, Busch AJ, et al. Cognitive behavioural therapies for fibromyalgia. Cochrane Database Syst Rev. 2013;(9):CD009796.

• 全文
• 摘要

72.  Bidonde J, Busch AJ, Webber SC, et al. Aquatic exercise training for fibromyalgia. Cochrane Database Syst Rev. 2014;(10):CD011336.

• 全文
• 摘要

73.  Barker AL, Talevski J, Morello RT, et al. Effectiveness of aquatic exercise for musculoskeletal conditions: a meta-analysis. Arch Phys Med Rehabil. 2014;95:1776-1786.

• 摘要

74.  Williams DA, Kuper D, Segar M, et al. Internet-enhanced management of fibromyalgia: a randomized controlled trial. Pain. 2010;151:694-702.

• 摘要

75.  Luciano JV, Sabes-Figuera R, Cardeñosa E, et al. Cost-utility of a psychoeducational intervention in fibromyalgia patients compared with usual care: an economic evaluation alongside a 12-month randomized controlled trial. Clin J Pain. 2013;29:702-711.

• 摘要

76.  Mhalla A, Baudic S, Ciampi de Andrade D, et al. Long-term maintenance of the analgesic effects of transcranial magnetic stimulation in fibromyalgia. Pain. 2011;152:1478-1485.

• 摘要

77.  O'Connell NE, Wand BM, Marston L, et al. Non-invasive brain stimulation techniques for chronic pain. Cochrane Database Syst Rev. 2014;(4):CD008208.

• 全文
• 摘要

78.  Fagerlund AJ, Hansen OA, Aslaksen PM. Transcranial direct current stimulation as a treatment for patients with fibromyalgia: a randomized controlled trial. Pain. 2015;156:62-71.

• 摘要

79.  Schneider M, Vernon H, Ko G, et al. Chiropractic management of fibromyalgia syndrome: a systematic review of the literature. J Manipulative Physiol Ther. 2009;32:25-40.

• 摘要

80.  Bronfort GH, Haas M, Evans R, et al. Effectiveness of manual therapies: The UK evidence report. Chiroprac Osteopat. 2010;18:3.

• 全文

81.  Kalichman L. Massage therapy for fibromyalgia symptoms. Rheumatol Int. 2010;30:1151-1157.

• 摘要

82.  Ernst E. Chiropractic treatment for fibromyalgia: a systematic review. Clin Rheumatol. 2009;28:1175-1178.

• 摘要

83.  Lange G. Vagus nerve stimulation in fibromyalgia. National Institute of Arthritis and Musculoskeletal and Skin Diseases grant 5R01AR053732-03. http://projectreporter.nih.gov/ (last accessed 18 August 2017).

• 全文

84.  Radvanski DC, Vaschillo EG, Vaschillo B, et al. A pilot study of the efficacy of heart rate variability (HRV) biofeedback in patients with fibromyalgia. App Psychophys Biofeedback. 2007;32:1-10.

• 摘要

85.  Babu AS, Mathew E, Danda D, et al. Management of patients with fibromyalgia using biofeedback: a randomized control trial. Indian J Med Sci. 2007;61:455-461.

• 摘要

86.  Assefi NP, Sherman KJ, Jacobsen C, et al. A randomized clinical trial of acupuncture compared with sham acupuncture in fibromyalgia. Ann Intern Med. 2005;143:10-19.

• 摘要

87.  Martin DP, Sletten CD, Williams BA, et al. Improvement in fibromyalgia symptoms with acupuncture: results of a randomized controlled trial. Mayo Clin Proc. 2006;81:749-757.

• 摘要

88.  Rooks DS. Fibromyalgia treatment update. Curr Opin Rheumatol. 2007;19:111-117.

• 摘要

89.  Martin-Sanchez E, Torralba E, Díaz-Domínguez E, et al. Efficacy of acupuncture for the treatment of fibromyalgia: systematic review and meta-analysis of randomized trials. Open Rheumatol J. 2009;3:25-29.

• 摘要

90.  Cao H, Liu J, Lewith GT. Traditional Chinese Medicine for treatment of fibromyalgia: a systematic review of randomized controlled trials. J Altern Complement Med. 2010;16:397-409.

• 摘要

91.  Perry R, Terry R, Ernst E. A systematic review of homoeopathy for the treatment of fibromyalgia. Clin Rheumatol. 2010;29:457-464.

• 摘要

92.  Porter NS, Jason LA, Boulton A, et al. Alternative medical interventions used in the treatment and management of myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia. J Altern Complement Med. 2010;16:235-249.

• 摘要

93.  Russell IJ, Holman AJ, Swick TJ, et al. Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study. Pain. 2011;152:1007-1017.

• 摘要

94.  Russell IJ, Bennett RM, Michalek JE. Sodium oxybate relieves pain and improves sleep in fibromyalgia syndrome (FMS): a randomized, double-blind, placebo-controlled, multi-center clinical trial. Presented at the 69th Annual Meeting of the American College of Rheumatology, 2005. Arthritis Rheum. 2005;52(suppl 9):abstract L30.

95.  Younger J, Mackey S. Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study. Pain Med. 2009;10:663-672.

• 全文
• 摘要

96.  Lynch ME, Campbell F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol. 2011;72:735-744.

• 全文
• 摘要

97.  Cohen SP, Verdolin MH, Chang AS, et al. The intravenous ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients. J Pain. 2006;7:391-398.

• 摘要

98.  Olivan-Blázquez B, Herrera-Mercadal P, Puebla-Guedea M, et al. Efficacy of memantine in the treatment of fibromyalgia: a double-blind, randomised, controlled trial with 6-month follow-up. Pain. 2014;155:2517-2525.

• 摘要

99.  Chen KW, Hassett AL, Hou F, et al. A pilot study of external qigong therapy for patients with fibromyalgia. J Altern Complement Med. 2006;12:851-856.

• 摘要

100.  Langhorst J, Musial F, Klose P, et al. Efficacy of hydrotherapy in fibromyalgia syndrome - a meta-analysis of randomized controlled clinical trials. Rheumatology (Oxford). 2009;48:1155-1159.

• 摘要

101.  Silber MH. Chronic insomnia. N Engl J Med. 2005;353:803-810.

• 摘要